PATENT CLAIM ANALYSIS

Application Number: 16143079
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["424", "204100"]

Abstract:
The present invention relates to polymerized recombinant proteins, to recombinant nucleic acids coding for the polymerized recombinant proteins, to expression cassettes comprising the recombinant nucleic acids, to host cells transformed by the expression cassettes and to a method for multimerizing a recombinant protein. The polymerized proteins of the invention may be used in pharmaceutical or immunogenic compositions. In particular, the recombinant proteins may be antigens, antibodies or scaffolds. In particular, the polymerized recombinant protein may be an influenza haemagglutinin.

Claim (Index 5):
The molecule according to any one of  claims 1  to  4  which comprises cysteine residues at the positions within the molecule corresponding to positions 2, 7, 13, 19, 21, 24 and 27 of SEQ ID NO:1.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 97.0
- Lexical Diversity: 2.02273
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15536726', '15117811', '14649500', '13185157', '10327673']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7227203667154558
- 35 USC 102 Novelty (BERT): 0.6080649919223988
- Combined Prediction Score: 0.7112548292361501
- Mean Citation Score: 360.564174
- Max Citation Score: 596.6024
- Similarity Product: 438.77263945479393

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test